首页 > 最新文献

Asian Pacific journal of allergy and immunology最新文献

英文 中文
Characteristics of immediate hypersensitivity reaction to paclitaxel-based chemotherapy in gynecologic cancer patients. 妇科肿瘤患者紫杉醇类化疗即刻超敏反应的特点。
IF 5 4区 医学 Q3 ALLERGY Pub Date : 2023-12-01 DOI: 10.12932/AP-050520-0831
Thitinan Thangwonglers, Wichai Santimaleeworagun, Suwanit Therasakvichya, Nuttapat Saengsukkasemsak, Piyarat Pimsi

Background: Immediate hypersensitivity reactions (IHRs) are commonly found in patients receiving paclitaxel. Effects of paclitaxel vary because of variable co-therapy or re-challenge with paclitaxel.

Objective: Our objective was to investigate the incidence, patterns, and risk factors for paclitaxel-related IHRs and management of IHRs in gynecologic malignancy patients.

Methods: This retrospective study was performed in gynecologic cancer patients receiving paclitaxel-based regimens at Siriraj hospital from January 2012 to December 2017.

Results: 416 subjects were included and received ranitidine 50 mg, dexamethasone 20 mg, ondansetron 16 mg intravenously and diphenhydramine 50 mg orally 30 minutes before starting chemotherapy. The incidence of IHRs was 17.79%. IHRs occurring on first exposure to paclitaxel was 81.1% and occurred within 30 minutes after starting paclitaxel. The most commonly found presentation of IHRs were skin reactions (86.5%). In multivariate analysis, age < 54.5 years, stage of cancer < 2, and leukocyte cell count < 7.735 × 109/L were significantly associated with IHRs. Seventy-two out of 74 patients that recovered from IHRs were reintroduced paclitaxel. Forty-seven patients (97.92%) of 48 patients with mild reactions were successfully reintroduced to paclitaxel after treatment with chlorpheniramine or other interventions.

Conclusions: The incidence of paclitaxel-related IHRs was about one in five. Skin reactions were the most commonly occurring reactions. Younger age, stage of cancer < 2, and leukocytes < 7.735 × 109/L were significant risk factors for IHRs. Patients with IHRs recovered without the use of dexamethasone and antihistamines before the reintroduction of paclitaxel.

背景:立即过敏反应(IHRs)常见于接受紫杉醇治疗的患者。紫杉醇的作用因不同的联合治疗或与紫杉醇的再挑战而不同。目的:我们的目的是调查妇科恶性肿瘤患者紫杉醇相关ihr的发生率、模式和危险因素以及ihr的管理。方法:回顾性研究2012年1月至2017年12月在Siriraj医院接受紫杉醇类方案治疗的妇科癌症患者。结果:纳入416例患者,化疗前30分钟静脉滴注雷尼替丁50 mg,地塞米松20 mg,昂丹西琼16 mg,口服苯海拉明50 mg。IHRs的发生率为17.79%。首次接触紫杉醇的ihr发生率为81.1%,发生在紫杉醇启动后30分钟内。最常见的ihr表现是皮肤反应(86.5%)。在多因素分析中,年龄< 54.5岁、肿瘤分期< 2期、白细胞计数< 7.735 × 109/L与ihr显著相关。74例ihr恢复患者中72例重新引入紫杉醇。48例轻度反应患者中有47例(97.92%)在用氯苯那敏或其他干预措施治疗后成功重新使用紫杉醇。结论:紫杉醇相关ihr的发生率约为1 / 5。皮肤反应是最常见的反应。年龄小、肿瘤分期< 2期、白细胞< 7.735 × 109/L是ihr发生的重要危险因素。在重新引入紫杉醇之前,ihr患者在没有使用地塞米松和抗组胺药的情况下恢复。
{"title":"Characteristics of immediate hypersensitivity reaction to paclitaxel-based chemotherapy in gynecologic cancer patients.","authors":"Thitinan Thangwonglers, Wichai Santimaleeworagun, Suwanit Therasakvichya, Nuttapat Saengsukkasemsak, Piyarat Pimsi","doi":"10.12932/AP-050520-0831","DOIUrl":"10.12932/AP-050520-0831","url":null,"abstract":"<p><strong>Background: </strong>Immediate hypersensitivity reactions (IHRs) are commonly found in patients receiving paclitaxel. Effects of paclitaxel vary because of variable co-therapy or re-challenge with paclitaxel.</p><p><strong>Objective: </strong>Our objective was to investigate the incidence, patterns, and risk factors for paclitaxel-related IHRs and management of IHRs in gynecologic malignancy patients.</p><p><strong>Methods: </strong>This retrospective study was performed in gynecologic cancer patients receiving paclitaxel-based regimens at Siriraj hospital from January 2012 to December 2017.</p><p><strong>Results: </strong>416 subjects were included and received ranitidine 50 mg, dexamethasone 20 mg, ondansetron 16 mg intravenously and diphenhydramine 50 mg orally 30 minutes before starting chemotherapy. The incidence of IHRs was 17.79%. IHRs occurring on first exposure to paclitaxel was 81.1% and occurred within 30 minutes after starting paclitaxel. The most commonly found presentation of IHRs were skin reactions (86.5%). In multivariate analysis, age < 54.5 years, stage of cancer < 2, and leukocyte cell count < 7.735 × 109/L were significantly associated with IHRs. Seventy-two out of 74 patients that recovered from IHRs were reintroduced paclitaxel. Forty-seven patients (97.92%) of 48 patients with mild reactions were successfully reintroduced to paclitaxel after treatment with chlorpheniramine or other interventions.</p><p><strong>Conclusions: </strong>The incidence of paclitaxel-related IHRs was about one in five. Skin reactions were the most commonly occurring reactions. Younger age, stage of cancer < 2, and leukocytes < 7.735 × 109/L were significant risk factors for IHRs. Patients with IHRs recovered without the use of dexamethasone and antihistamines before the reintroduction of paclitaxel.</p>","PeriodicalId":8552,"journal":{"name":"Asian Pacific journal of allergy and immunology","volume":" ","pages":"340-346"},"PeriodicalIF":5.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38500263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Epidemiological, clinical and economic burden of severe eosinophilic asthma in Taiwan: Results from a large tertiary care hospital. 台湾某大型三级医院重症嗜酸性哮喘的流行病学、临床及经济负担。
IF 5 4区 医学 Q3 ALLERGY Pub Date : 2023-12-01 DOI: 10.12932/AP-200220-0771
Sumitra Shantakumar, Yu-Fan Ho, Li-Wen Tuan, Tzu-Mei Lin, Alon Y Hershko, Yi-Hsing Chen

Background: Burden of severe eosinophilic asthma (SEA) data in Asia are limited.

Objective: This retrospective, observational study characterized SEA epidemiology, healthcare resource use (HCRU) and costs for adult patients in Taiwan.

Methods: Data from Taichung Veterans General Hospital electronic medical record database, between 2013 to 2016, were extracted. Eligible general asthma patients were ≥ 18 years at index date, with ≥ 1 medical claim with an asthma diagnosis after the index date. Patients with SEA (meeting additional criteria: Global Initiative for Asthma Step 4/5 treatment guidelines [within 3 months preceding index date], ≥ 2 clinically significant exacerbations, and eosinophil counts ≥ 300 cells/μL [within 12 months preceding index date] or ≥ 150 cells/μL [on index date]) and SEA patients using high-dose inhaled corticosteroids (HD ICS) were also identified. Twelve months' pre-index data were used to evaluate exacerbation frequency, treatment patterns, HCRU, and costs (2016 US Dollars).

Results: Of 2,601 eligible general asthmatic patients, 162 (6.2%) met predefined criteria for SEA; of SEA patients, 72/162 (44.4%) had used HD ICS. SEA and HD ICS SEA patients experienced more clinically significant exacerbations than general asthma patients (1.6 ± 3.3 and 1.5 ± 2.6 vs 0.6 ± 2.0, p < 0.01). HD ICS SEA and SEA patients incurred at least 2-2.5-fold higher total asthma-related and all-cause costs than general asthma patients and had significantly greater HCRU.

Conclusions: Of eligible Taiwanese general asthma patients, 6.2% met predefined SEA criteria. Compared with general asthma patients, SEA and HD ICS SEA patients used more respiratory medications, experienced more exacerbations, and incurred greater HCRU and higher costs.

背景:亚洲的严重嗜酸性粒细胞哮喘(SEA)负担数据有限。目的:本研究为回顾性观察性研究,探讨台湾地区成人SEA流行病学、医疗资源使用及医疗费用。方法:提取台中退伍军人总医院电子病历数据库2013 - 2016年的数据。符合条件的普通哮喘患者在索引日期≥18岁,在索引日期后有≥1例哮喘诊断的医疗索赔。SEA患者(符合额外标准:全球哮喘倡议步骤4/5治疗指南[在索引日期前3个月内],≥2次临床显著加重,嗜酸性粒细胞计数≥300细胞/μL[在索引日期前12个月内]或≥150细胞/μL[在索引日期])和使用大剂量吸入皮质类固醇(HD ICS)的SEA患者也被确定。使用指数前12个月的数据来评估恶化频率、治疗模式、HCRU和成本(2016年美元)。结果:2,601例符合条件的普通哮喘患者中,162例(6.2%)符合预先设定的SEA标准;在SEA患者中,72/162(44.4%)使用了HD ICS。SEA和HD ICS患者的临床显著加重程度高于普通哮喘患者(1.6±3.3和1.5±2.6 vs 0.6±2.0,p < 0.01)。HD ICS、SEA和SEA患者的总哮喘相关费用和全因费用至少是普通哮喘患者的2-2.5倍,HCRU显著高于普通哮喘患者。结论:在符合条件的台湾普通哮喘患者中,6.2%符合预先设定的SEA标准。与普通哮喘患者相比,SEA和HD ICS患者使用呼吸系统药物更多,加重次数更多,HCRU更高,费用更高。
{"title":"Epidemiological, clinical and economic burden of severe eosinophilic asthma in Taiwan: Results from a large tertiary care hospital.","authors":"Sumitra Shantakumar, Yu-Fan Ho, Li-Wen Tuan, Tzu-Mei Lin, Alon Y Hershko, Yi-Hsing Chen","doi":"10.12932/AP-200220-0771","DOIUrl":"10.12932/AP-200220-0771","url":null,"abstract":"<p><strong>Background: </strong>Burden of severe eosinophilic asthma (SEA) data in Asia are limited.</p><p><strong>Objective: </strong>This retrospective, observational study characterized SEA epidemiology, healthcare resource use (HCRU) and costs for adult patients in Taiwan.</p><p><strong>Methods: </strong>Data from Taichung Veterans General Hospital electronic medical record database, between 2013 to 2016, were extracted. Eligible general asthma patients were ≥ 18 years at index date, with ≥ 1 medical claim with an asthma diagnosis after the index date. Patients with SEA (meeting additional criteria: Global Initiative for Asthma Step 4/5 treatment guidelines [within 3 months preceding index date], ≥ 2 clinically significant exacerbations, and eosinophil counts ≥ 300 cells/μL [within 12 months preceding index date] or ≥ 150 cells/μL [on index date]) and SEA patients using high-dose inhaled corticosteroids (HD ICS) were also identified. Twelve months' pre-index data were used to evaluate exacerbation frequency, treatment patterns, HCRU, and costs (2016 US Dollars).</p><p><strong>Results: </strong>Of 2,601 eligible general asthmatic patients, 162 (6.2%) met predefined criteria for SEA; of SEA patients, 72/162 (44.4%) had used HD ICS. SEA and HD ICS SEA patients experienced more clinically significant exacerbations than general asthma patients (1.6 ± 3.3 and 1.5 ± 2.6 vs 0.6 ± 2.0, p < 0.01). HD ICS SEA and SEA patients incurred at least 2-2.5-fold higher total asthma-related and all-cause costs than general asthma patients and had significantly greater HCRU.</p><p><strong>Conclusions: </strong>Of eligible Taiwanese general asthma patients, 6.2% met predefined SEA criteria. Compared with general asthma patients, SEA and HD ICS SEA patients used more respiratory medications, experienced more exacerbations, and incurred greater HCRU and higher costs.</p>","PeriodicalId":8552,"journal":{"name":"Asian Pacific journal of allergy and immunology","volume":" ","pages":"325-335"},"PeriodicalIF":5.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38674192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The relationship between exposure to polycyclic aromatic hydrocarbons and adult atopic dermatitis. 多环芳烃暴露与成人特应性皮炎的关系。
IF 5 4区 医学 Q3 ALLERGY Pub Date : 2023-12-01 DOI: 10.12932/AP-210720-0926
Kuo-Tung Tang, Pin-An Chen, Maw-Rong Lee, Mey-Fann Lee, Yi-Hsing Chen

Background: Polycyclic aromatic hydrocarbons are one of the major pathogenic components in air pollution. Previous studies have demonstrated an association between air pollution and atopic dermatitis.

Objective: We sought to explore the relationship between polycyclic aromatic hydrocarbons exposure and adult atopic dermatitis.

Methods: We prospectively recruited 23 adult patients with atopic dermatitis and 11 healthy controls. Plasma levels of inflammatory cytokines were determined using enzyme-linked immunosorbent assay. Expression levels of aryl hydrocarbon receptor, which mediates the effect of polycyclic aromatic hydrocarbons, and cytokines in peripheral blood nuclear cells (PBMCs) were measured using reverse transcription polymerase chain reaction. Urine levels of 16 polycyclic aromatic hydrocarbon metabolites were determined by gas chromatography- tandem mass spectrometry.

Results: Patients with atopic dermatitis had lower levels of interleukin (IL)-5 and IL-23, and lower PBMC messenger RNA expression levels of interferon-> than the healthy controls. Plasma levels of IL-22 were moderately and positively associated with the SCORAD index. Creatinine-corrected urine levels of 9-hydroxyfluorene and 2-hydroxyphenanthrene were elevated in the atopic dermatitis group. However the difference was not statistically significant after Bonferroni correction.

Conclusions: Our results demonstrated that the polycyclic aromatic hydrocarbons fluorene and phenanthrene are potentially associated with the pathogenesis of atopic dermatitis in adults.

背景:多环芳烃是大气污染的主要致病成分之一。先前的研究已经证明了空气污染与特应性皮炎之间的联系。目的:探讨多环芳烃暴露与成人特应性皮炎的关系。方法:前瞻性招募23例成人特应性皮炎患者和11例健康对照。采用酶联免疫吸附法测定血浆炎症细胞因子水平。采用逆转录聚合酶链反应法测定外周血核细胞(PBMCs)中介导多环芳烃作用的芳烃受体(aryl hydrocarbon receptor)和细胞因子的表达水平。采用气相色谱-串联质谱法测定了尿中16种多环芳烃代谢物的含量。结果:特应性皮炎患者白细胞介素(IL)-5、IL-23水平低于正常对照组,PBMC信使RNA干扰素->表达水平低于正常对照组。血浆IL-22水平与SCORAD指数呈正相关。肌酸酐校正尿中9-羟基芴和2-羟基菲水平在特应性皮炎组升高。但经Bonferroni校正后,差异无统计学意义。结论:我们的研究结果表明,多环芳烃、芴和菲可能与成人特应性皮炎的发病机制有关。
{"title":"The relationship between exposure to polycyclic aromatic hydrocarbons and adult atopic dermatitis.","authors":"Kuo-Tung Tang, Pin-An Chen, Maw-Rong Lee, Mey-Fann Lee, Yi-Hsing Chen","doi":"10.12932/AP-210720-0926","DOIUrl":"10.12932/AP-210720-0926","url":null,"abstract":"<p><strong>Background: </strong>Polycyclic aromatic hydrocarbons are one of the major pathogenic components in air pollution. Previous studies have demonstrated an association between air pollution and atopic dermatitis.</p><p><strong>Objective: </strong>We sought to explore the relationship between polycyclic aromatic hydrocarbons exposure and adult atopic dermatitis.</p><p><strong>Methods: </strong>We prospectively recruited 23 adult patients with atopic dermatitis and 11 healthy controls. Plasma levels of inflammatory cytokines were determined using enzyme-linked immunosorbent assay. Expression levels of aryl hydrocarbon receptor, which mediates the effect of polycyclic aromatic hydrocarbons, and cytokines in peripheral blood nuclear cells (PBMCs) were measured using reverse transcription polymerase chain reaction. Urine levels of 16 polycyclic aromatic hydrocarbon metabolites were determined by gas chromatography- tandem mass spectrometry.</p><p><strong>Results: </strong>Patients with atopic dermatitis had lower levels of interleukin (IL)-5 and IL-23, and lower PBMC messenger RNA expression levels of interferon-> than the healthy controls. Plasma levels of IL-22 were moderately and positively associated with the SCORAD index. Creatinine-corrected urine levels of 9-hydroxyfluorene and 2-hydroxyphenanthrene were elevated in the atopic dermatitis group. However the difference was not statistically significant after Bonferroni correction.</p><p><strong>Conclusions: </strong>Our results demonstrated that the polycyclic aromatic hydrocarbons fluorene and phenanthrene are potentially associated with the pathogenesis of atopic dermatitis in adults.</p>","PeriodicalId":8552,"journal":{"name":"Asian Pacific journal of allergy and immunology","volume":" ","pages":"311-317"},"PeriodicalIF":5.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38674687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Meta-analysis and cost-effectiveness analysis of intranasal corticosteroid treatment in allergic rhinitis with ocular symptoms. 鼻内皮质类固醇治疗伴有眼部症状的过敏性鼻炎的荟萃分析和成本效益分析。
IF 5 4区 医学 Q3 ALLERGY Pub Date : 2023-12-01 DOI: 10.12932/AP-070823-1669
Chadakan Yan, Phichayut Phinyo, Bussakorn Mahakkanukrauh, Torsak Bunupuradah, Manish Verma, Abhay Phansalkar, Bhumika Aggarwal
BACKGROUND Intranasal corticosteroid (INCS) has a beneficial effect on ocular symptoms in allergic rhinitis (AR). To our knowledge, the cost-effectiveness of available INCS for AR with ocular symptoms is yet to be demonstrated. OBJECTIVE To evaluate the cost-effectiveness of INCSs including Budesonide (BANS), Mometasone furoate (MFNS), Triamcinolone (TANS), and Fluticasone furoate (FFNS) on ocular symptoms associated with AR in the Thai context. METHODS The percentage of effectiveness in improving total ocular symptoms score (TOSS) was derived from the result of a meta-analysis that estimated the SMD of each INCS treatment compared to placebo as clinical input parameters. A cost-effectiveness analysis based on a decision-tree model to assess one-year costs and outcomes from a Thai societal perspective. The outcomes were to compare incremental cost-effectiveness ratio (ICER). Probabilistic sensitivity analyses (PSA) were also conducted to capture parameter uncertainties. RESULTS 13 eligible RCTs with a total of 3,722 patients with SAR were included in the analysis. The percentage of effectiveness of FFNS, MFNS, TANS, and BANS was 59.89%, 45.60%, 24.89%, and 16.00%, respectively. The ICER of FFNS, MFNS, and TANS is THB-6,539.92, 4,593.83, and 1,401.24 compared to BANS. CECA result showed the probability of using FFNS is considered cost-effective in 87.50% of cases from zero value followed by MFNS (0.80%), TANS (5.40%), and BANS (6.30%). With a threshold greater than THB20,000, FFNS is considered a cost-effective strategy. CONCLUSIONS FFNS is a cost-effective option compared to alternative INCSs in Thailand for treating AR with ocular symptoms.
背景:鼻内皮质类固醇(INCS)对变应性鼻炎(AR)的眼部症状有良好的治疗作用。据我们所知,现有INCS治疗眼部症状AR的成本效益尚待证明。目的:评估包括布地奈德(BANS)、糠酸莫米松(MFNS)、曲安奈德(TANS)和糠酸氟替卡松(FFNS)在内的INCS在泰国治疗AR相关眼部症状的成本效益。方法:改善眼部症状总分(TOSS)的有效性百分比来自一项荟萃分析的结果,该荟萃分析估计了与安慰剂相比,每种INCS治疗的SMD作为临床输入参数。基于决策树模型的成本效益分析,从泰国社会角度评估一年的成本和结果。结果是比较增量成本效益比(ICER)。还进行了概率灵敏度分析(PSA),以捕捉参数的不确定性。结果:13项符合条件的随机对照试验纳入分析,共3722名SAR患者。FFNS、MFNS、TANS和BANS的有效率分别为59.89%、45.60%、24.89%和16.00%。与BANS相比,FFNS、MFNS和TANS的ICER分别为THB-6539.92、4593.83和1401.24。CECA结果显示,在87.50%的病例中,使用FFNS的概率被认为是具有成本效益的,从零值开始,其次是MFNS(0.80%)、TANS(5.40%)和BANS(6.30%)。阈值大于THB20000时,FFNS被认为是一种具有成本效益。结论:与泰国的替代INCS相比,FFNS是一种治疗AR伴眼部症状的成本效益高的选择。
{"title":"Meta-analysis and cost-effectiveness analysis of intranasal corticosteroid treatment in allergic rhinitis with ocular symptoms.","authors":"Chadakan Yan, Phichayut Phinyo, Bussakorn Mahakkanukrauh, Torsak Bunupuradah, Manish Verma, Abhay Phansalkar, Bhumika Aggarwal","doi":"10.12932/AP-070823-1669","DOIUrl":"10.12932/AP-070823-1669","url":null,"abstract":"BACKGROUND Intranasal corticosteroid (INCS) has a beneficial effect on ocular symptoms in allergic rhinitis (AR). To our knowledge, the cost-effectiveness of available INCS for AR with ocular symptoms is yet to be demonstrated. OBJECTIVE To evaluate the cost-effectiveness of INCSs including Budesonide (BANS), Mometasone furoate (MFNS), Triamcinolone (TANS), and Fluticasone furoate (FFNS) on ocular symptoms associated with AR in the Thai context. METHODS The percentage of effectiveness in improving total ocular symptoms score (TOSS) was derived from the result of a meta-analysis that estimated the SMD of each INCS treatment compared to placebo as clinical input parameters. A cost-effectiveness analysis based on a decision-tree model to assess one-year costs and outcomes from a Thai societal perspective. The outcomes were to compare incremental cost-effectiveness ratio (ICER). Probabilistic sensitivity analyses (PSA) were also conducted to capture parameter uncertainties. RESULTS 13 eligible RCTs with a total of 3,722 patients with SAR were included in the analysis. The percentage of effectiveness of FFNS, MFNS, TANS, and BANS was 59.89%, 45.60%, 24.89%, and 16.00%, respectively. The ICER of FFNS, MFNS, and TANS is THB-6,539.92, 4,593.83, and 1,401.24 compared to BANS. CECA result showed the probability of using FFNS is considered cost-effective in 87.50% of cases from zero value followed by MFNS (0.80%), TANS (5.40%), and BANS (6.30%). With a threshold greater than THB20,000, FFNS is considered a cost-effective strategy. CONCLUSIONS FFNS is a cost-effective option compared to alternative INCSs in Thailand for treating AR with ocular symptoms.","PeriodicalId":8552,"journal":{"name":"Asian Pacific journal of allergy and immunology","volume":" ","pages":"263-272"},"PeriodicalIF":5.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49688587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synergy of interleukin-4 and interferon-γ in arginase-1 production in RAW264.7 macrophages. 白细胞介素-4和干扰素-γ在RAW264.7巨噬细胞精氨酸酶-1生成中的协同作用
IF 5 4区 医学 Q3 ALLERGY Pub Date : 2023-12-01 DOI: 10.12932/AP-160221-1067
Tomoko Hinse Endo, Natsumi Mizuno, Saeko Matsuda, Saki Shiga, Yoshiki Yanagawa

Background: Interferon (IFN)-γ and interleukin (IL)-4 are considered to be important factors to regulate immune responses. Although the effects of IFN-γ or IL-4 on macrophage functions are well established, their cooperative action is not fully understood.

Objective: Inducible nitric oxide synthase (iNOS) or arginase (Arg)-1 is a representative marker of M1 or M2 macrophages and plays a role in the acceleration or suppression of inflammatory responses. In the present study, we examined the effect of simultaneous treatment with IFN-γ and IL-4 on macrophage expression of iNOS and Arg-1 using the murine macrophage cell line RAW264.7.

Methods: Protein production and mRNA expression of iNOS and Arg-1 were measured using immunoblotting and reverse transcription-polymerase chain reaction. Cell surface expression of CD86 and programmed death ligand (PD-L) 2 was analyzed using flow cytometry.

Results: IFN-γ or IL-4 increased iNOS or Arg-1 protein production, respectively. Of note, IL-4 combined with IFN-γ synergistically increased Arg-1 protein production, whereas IL-4 inhibited IFN-γ-induced iNOS production. This phenomenon was consistent with the mRNA levels. In addition, IL-4 combined with IFN-γ synergistically increased cell surface expression of PD-L2, which is involved in T cell suppression, whereas IL-4 completely inhibited IFN-γ-induced expression of CD86, which is responsible for T cell activation.

Conclusions: In the present study, we found the synergy of IFN-γ and IL-4 in Arg-1 and PD-L2 expression. Thus, macrophages highly expressing Arg-1 and PD-L2 may be induced by both IFN-γ and IL-4 at the inflammatory site, and might play a role in the regulation of inflammatory immune responses.

背景:干扰素(IFN)-γ和白细胞介素(IL)-4被认为是调节免疫应答的重要因子。虽然IFN-γ或IL-4对巨噬细胞功能的影响已经确定,但它们的协同作用尚未完全了解。目的:诱导型一氧化氮合酶(iNOS)或精氨酸酶(Arg)-1是M1或M2巨噬细胞的代表性标志物,具有加速或抑制炎症反应的作用。在本研究中,我们利用小鼠巨噬细胞系RAW264.7检测了IFN-γ和IL-4同时处理对巨噬细胞iNOS和Arg-1表达的影响。方法:采用免疫印迹法和逆转录聚合酶链反应法检测iNOS和Arg-1的蛋白产量和mRNA表达。流式细胞术分析细胞表面CD86和程序性死亡配体(PD-L) 2的表达。结果:IFN-γ或IL-4分别增加了iNOS或Arg-1蛋白的产生。值得注意的是,IL-4与IFN-γ联合可协同增加Arg-1蛋白的产生,而IL-4则抑制IFN-γ诱导的iNOS的产生。这一现象与mRNA水平一致。此外,IL-4与IFN-γ联合可协同提高细胞表面PD-L2的表达,而IL-4完全抑制IFN-γ诱导的CD86的表达,而CD86负责T细胞活化。结论:在本研究中,我们发现IFN-γ和IL-4在Arg-1和PD-L2表达中的协同作用。因此,高表达Arg-1和PD-L2的巨噬细胞可能在炎症部位受到IFN-γ和IL-4的诱导,并可能在炎症免疫反应中发挥调节作用。
{"title":"Synergy of interleukin-4 and interferon-γ in arginase-1 production in RAW264.7 macrophages.","authors":"Tomoko Hinse Endo, Natsumi Mizuno, Saeko Matsuda, Saki Shiga, Yoshiki Yanagawa","doi":"10.12932/AP-160221-1067","DOIUrl":"10.12932/AP-160221-1067","url":null,"abstract":"<p><strong>Background: </strong>Interferon (IFN)-γ and interleukin (IL)-4 are considered to be important factors to regulate immune responses. Although the effects of IFN-γ or IL-4 on macrophage functions are well established, their cooperative action is not fully understood.</p><p><strong>Objective: </strong>Inducible nitric oxide synthase (iNOS) or arginase (Arg)-1 is a representative marker of M1 or M2 macrophages and plays a role in the acceleration or suppression of inflammatory responses. In the present study, we examined the effect of simultaneous treatment with IFN-γ and IL-4 on macrophage expression of iNOS and Arg-1 using the murine macrophage cell line RAW264.7.</p><p><strong>Methods: </strong>Protein production and mRNA expression of iNOS and Arg-1 were measured using immunoblotting and reverse transcription-polymerase chain reaction. Cell surface expression of CD86 and programmed death ligand (PD-L) 2 was analyzed using flow cytometry.</p><p><strong>Results: </strong>IFN-γ or IL-4 increased iNOS or Arg-1 protein production, respectively. Of note, IL-4 combined with IFN-γ synergistically increased Arg-1 protein production, whereas IL-4 inhibited IFN-γ-induced iNOS production. This phenomenon was consistent with the mRNA levels. In addition, IL-4 combined with IFN-γ synergistically increased cell surface expression of PD-L2, which is involved in T cell suppression, whereas IL-4 completely inhibited IFN-γ-induced expression of CD86, which is responsible for T cell activation.</p><p><strong>Conclusions: </strong>In the present study, we found the synergy of IFN-γ and IL-4 in Arg-1 and PD-L2 expression. Thus, macrophages highly expressing Arg-1 and PD-L2 may be induced by both IFN-γ and IL-4 at the inflammatory site, and might play a role in the regulation of inflammatory immune responses.</p>","PeriodicalId":8552,"journal":{"name":"Asian Pacific journal of allergy and immunology","volume":" ","pages":"379-388"},"PeriodicalIF":5.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39432380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Does Trimethoprim-Sulfamethoxazole prophylaxis induce myelosuppression in primary immune deficiency disease patients; A retrospective, 3 groups comparative study. 甲氧苄啶-磺胺甲恶唑预防原发性免疫缺乏症患者骨髓抑制回顾性、三组比较研究。
IF 5 4区 医学 Q3 ALLERGY Pub Date : 2023-12-01 DOI: 10.12932/AP-050320-0782
Reem Elajez, Sabha Nisar, Mehdi Adeli

Background: The possible myelosuppression side effect of Trimethoprim-Sulfamethoxazole (TMP-SMX) on primary immune deficiency (PID) patients has not been established yet.

Objective: Identify if the PID patients are at higher risk of developing myelosuppression secondary to the use of TMPSMX.

Methods: Retrospective, three groups study, of PID patients (on and off TMP-SMX prophylaxis) and urinary tract infection (UTI) patients received prophylaxis TMP-SMX. Data about CBC results (WBC, ANC, Lymphocytes, RBC, Hemoglobin, and Platelet counts) at baseline, first, and maximum myelosuppression observed during the period of TMP-SMX administration were collected.

Results: A total of 122 patients were included in this study (41 PID patients on TMP-SMX prophylaxis, 45 PID patients not on TMP-SMX prophylaxis, and 36 UTI patients on prophylaxis TMP-SMX). There are significant differences noticed in the percentage of patients who developed clinical myelosuppression (i.e. less than normal value for age) in ANC (39.0% vs. 8.9% vs. 16.7%, p = 0.002), RBC (36.6% vs. 13.3% vs. 13.9%, p = 0.014), WBC (41.5% vs. 13.3% vs. 13.9%, p = 0.003), and platelet (24.4% vs. 15.6% vs. 2.8%, p = 0.028) in group 1, 2, and 3, respectively. Significant difference in myelosuppression between the groups was most likely due to the combination of TMP-SMX effect on PID patients rather than the disease or the drug itself.

Conclusions: Primary immune deficiency (PID) patients are at higher risk of developing myelosuppression secondary to TMP-SMX prophylaxis (especially ANC) comparing to immune-competent patients or other PID patients who did not receive prophylactic TMP-SMX. Future larger prospective study is required to confirm this association.

背景:甲氧苄啶-磺胺甲恶唑(TMP-SMX)对原发性免疫缺陷(PID)患者可能产生的骨髓抑制副作用尚未确定。目的:确定使用TMPSMX后,PID患者发生骨髓抑制的风险是否更高。方法:回顾性研究,三组PID患者(使用和不使用TMP-SMX预防)和尿路感染(UTI)患者接受TMP-SMX预防。首先收集基线时的CBC结果(WBC、ANC、淋巴细胞、RBC、血红蛋白和血小板计数)数据,以及在给药期间观察到的最大骨髓抑制数据。结果:本研究共纳入122例患者,其中41例盆腔炎患者采用TMP-SMX预防,45例盆腔炎患者未采用TMP-SMX预防,36例UTI患者采用TMP-SMX预防。在1组、2组和3组中,出现临床骨髓抑制(即低于年龄正常值)的患者比例分别为ANC(39.0%比8.9%比16.7%,p = 0.002)、RBC(36.6%比13.3%比13.9%,p = 0.014)、WBC(41.5%比13.3%比13.9%,p = 0.003)和血小板(24.4%比15.6%比2.8%,p = 0.028),差异有统计学意义。两组间骨髓抑制的显著差异最有可能是由于TMP-SMX对PID患者的联合作用,而不是疾病或药物本身。结论:与免疫正常的患者或未接受预防性TMP-SMX的其他原发性免疫缺陷(PID)患者相比,原发性免疫缺陷(PID)患者继发于TMP-SMX预防(尤其是ANC)的骨髓抑制风险更高。需要未来更大规模的前瞻性研究来证实这种关联。
{"title":"Does Trimethoprim-Sulfamethoxazole prophylaxis induce myelosuppression in primary immune deficiency disease patients; A retrospective, 3 groups comparative study.","authors":"Reem Elajez, Sabha Nisar, Mehdi Adeli","doi":"10.12932/AP-050320-0782","DOIUrl":"10.12932/AP-050320-0782","url":null,"abstract":"<p><strong>Background: </strong>The possible myelosuppression side effect of Trimethoprim-Sulfamethoxazole (TMP-SMX) on primary immune deficiency (PID) patients has not been established yet.</p><p><strong>Objective: </strong>Identify if the PID patients are at higher risk of developing myelosuppression secondary to the use of TMPSMX.</p><p><strong>Methods: </strong>Retrospective, three groups study, of PID patients (on and off TMP-SMX prophylaxis) and urinary tract infection (UTI) patients received prophylaxis TMP-SMX. Data about CBC results (WBC, ANC, Lymphocytes, RBC, Hemoglobin, and Platelet counts) at baseline, first, and maximum myelosuppression observed during the period of TMP-SMX administration were collected.</p><p><strong>Results: </strong>A total of 122 patients were included in this study (41 PID patients on TMP-SMX prophylaxis, 45 PID patients not on TMP-SMX prophylaxis, and 36 UTI patients on prophylaxis TMP-SMX). There are significant differences noticed in the percentage of patients who developed clinical myelosuppression (i.e. less than normal value for age) in ANC (39.0% vs. 8.9% vs. 16.7%, p = 0.002), RBC (36.6% vs. 13.3% vs. 13.9%, p = 0.014), WBC (41.5% vs. 13.3% vs. 13.9%, p = 0.003), and platelet (24.4% vs. 15.6% vs. 2.8%, p = 0.028) in group 1, 2, and 3, respectively. Significant difference in myelosuppression between the groups was most likely due to the combination of TMP-SMX effect on PID patients rather than the disease or the drug itself.</p><p><strong>Conclusions: </strong>Primary immune deficiency (PID) patients are at higher risk of developing myelosuppression secondary to TMP-SMX prophylaxis (especially ANC) comparing to immune-competent patients or other PID patients who did not receive prophylactic TMP-SMX. Future larger prospective study is required to confirm this association.</p>","PeriodicalId":8552,"journal":{"name":"Asian Pacific journal of allergy and immunology","volume":" ","pages":"353-360"},"PeriodicalIF":5.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38500261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparison of cell-culture plasticwares for effective human cytokine-induced killer cell culture. 细胞培养塑料器皿对人细胞因子诱导杀伤细胞培养效果的比较。
IF 5 4区 医学 Q3 ALLERGY Pub Date : 2023-12-01 DOI: 10.12932/AP-140720-0913
Panwadee Pluangnooch, Chaiphichit Phayangkhe, Kitipong Soontrapa

Background: Cytokine-induced killer (CIK) cells are ex-vivo expanded T cells which present a phenotype of both T and Natural Killer cell properties.

Objective: To compare the proliferation and functional properties of human CIK cells cultured in three cell culture plasticwares.

Methods: The number and viability of CIK cells were monitored. The expression of surface markers (CD3 and CD56), TH1 cytokines (IFN-γ and TNF-α), and cytolytic granules (granzyme B and perforin) were determined by flow cytometry.

Results: The number of CIK cells cultured in a static bag was highest compared to those in a petri dish and gas-permeable flask. However, CIK cells cultured in all plasticwares similarity expressed surface marker, TH1 cytokines, and cytolytic granules.

Conclusions: Considering safety, efficacy, and cost, a static bag is the best plasticware for culturing CIK cells.

背景:细胞因子诱导的杀伤细胞(CIK)是体外扩增的T细胞,具有T细胞和自然杀伤细胞的表型。目的:比较三种细胞培养塑料器皿培养人CIK细胞的增殖和功能特性。方法:监测CIK细胞的数量和活力。流式细胞术检测细胞表面标志物(CD3和CD56)、TH1细胞因子(IFN-γ和TNF-α)和细胞溶解颗粒(颗粒酶B和穿孔素)的表达。结果:与培养皿和透气瓶培养的CIK细胞相比,静袋培养的CIK细胞数量最多。然而,在所有塑料器皿中培养的CIK细胞都表达表面标记物、TH1细胞因子和细胞溶解颗粒。结论:综合考虑安全性、有效性和成本,静态袋是培养CIK细胞的最佳塑料器皿。
{"title":"A comparison of cell-culture plasticwares for effective human cytokine-induced killer cell culture.","authors":"Panwadee Pluangnooch, Chaiphichit Phayangkhe, Kitipong Soontrapa","doi":"10.12932/AP-140720-0913","DOIUrl":"10.12932/AP-140720-0913","url":null,"abstract":"<p><strong>Background: </strong>Cytokine-induced killer (CIK) cells are ex-vivo expanded T cells which present a phenotype of both T and Natural Killer cell properties.</p><p><strong>Objective: </strong>To compare the proliferation and functional properties of human CIK cells cultured in three cell culture plasticwares.</p><p><strong>Methods: </strong>The number and viability of CIK cells were monitored. The expression of surface markers (CD3 and CD56), TH1 cytokines (IFN-γ and TNF-α), and cytolytic granules (granzyme B and perforin) were determined by flow cytometry.</p><p><strong>Results: </strong>The number of CIK cells cultured in a static bag was highest compared to those in a petri dish and gas-permeable flask. However, CIK cells cultured in all plasticwares similarity expressed surface marker, TH1 cytokines, and cytolytic granules.</p><p><strong>Conclusions: </strong>Considering safety, efficacy, and cost, a static bag is the best plasticware for culturing CIK cells.</p>","PeriodicalId":8552,"journal":{"name":"Asian Pacific journal of allergy and immunology","volume":" ","pages":"401-406"},"PeriodicalIF":5.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38673743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validity and reliability of the Thai version of Food Allergy Quality of Life Questionnaire - Adult Form (FAQLQ-AF) and Food Allergy Independent Measure - Adult Form (FAIM-AF). 泰国版食品过敏生活质量问卷-成人版(FAQLQ-AF)和食品过敏独立测量-成人版的有效性和可靠性。
IF 5 4区 医学 Q3 ALLERGY Pub Date : 2023-10-23 DOI: 10.12932/AP-060323-1559
Chayapat Tangwiwat, Mongkhon Sompornrattanaphan, Torpong Thongngarm, Chamard Wongsa

Background: Food allergy affects the patient's quality of life (QoL) and leads to anxiety and depression. In addition to routine treatment, QoL evaluation should also be performed in patients with food allergies. The validated Food Allergy Quality of Life Questionnaire - Adult Form (FAQLQ-AF) and Food Allergy Independent Measure - Adult Form (FAIM-AF) have been well accepted and available in many languages.

Objective: Translate FAQLQ-AF and FAIM-AF into Thai and perform reliability and validity tests in Thai adult patients with food allergies.

Methods: The translation process was performed according to the ISPOR Task Force for Translation and Cultural Adaptation. Participants 18 years or older and with physician-diagnosed food allergies were included in the study. Thai versions of FAQLQ-AF and FAIM-AF were administered to participants at baseline and after two weeks. The intraclass correlation coefficient and Cronbach's α coefficient were evaluated to demonstrate both questionnaires' test-retest reliability and internal consistency.

Results: The study included 104 participants. The Thai version of FAQLQ-AF and FAIM-AF demonstrated good reliability, with intraclass correlation coefficients of 0.83 (95%CI 0.76, 0.88) and 0.85 (95%CI 0.79, 0.90), respectively. The validity was excellent, with Cronbach's α coefficient of 0.91 and 0.92, respectively. Both questionnaires were moderately correlated (r = 0.69, P < 0.001), but poorly correlated with the 36-Item Short Form Survey, which is usually used to evaluate general health status.

Conclusions: To evaluate the QoL in adult patients with food allergies, the Thai versions of FAQLQ-AF and FAIM-AF are valid, reliable, and more suitable than the general questionnaire.

背景:食物过敏会影响患者的生活质量,并导致焦虑和抑郁。除了常规治疗外,食物过敏患者还应进行生活质量评估。经验证的食品过敏生活质量问卷-成人版(FAQLQ-AF)和食品过敏独立测量-成人版已被广泛接受,并有多种语言版本。目的:将FAQLQ-AF和FAIM-AF翻译成泰语,并对泰国成年食物过敏患者进行信度和有效性测试。方法:按照ISPOR翻译和文化适应工作组的要求进行翻译。18岁或18岁以上且经医生诊断为食物过敏的参与者被纳入研究。泰国版本的FAQLQ-AF和FAIM-AF在基线和两周后给参与者服用。评估组内相关系数和Cronbachα系数,以证明两份问卷的重测可靠性和内部一致性。结果:该研究包括104名参与者。泰国版的FAQLQ-AF和FAIM-AF显示出良好的可靠性,组内相关系数分别为0.83(95%CI 0.76,0.88)和0.85(95%CI 0.7 9,0.90)。有效性非常好,Cronbachα系数分别为0.91和0.92。两份问卷均具有中等相关性(r=0.69,P<0.001),但与通常用于评估总体健康状况的36项简式调查相关性较差。结论:为了评估成年食物过敏患者的生活质量,泰国版的FAQLQ-AF和FAIM-AF是有效、可靠的,并且比普通问卷更适合。
{"title":"Validity and reliability of the Thai version of Food Allergy Quality of Life Questionnaire - Adult Form (FAQLQ-AF) and Food Allergy Independent Measure - Adult Form (FAIM-AF).","authors":"Chayapat Tangwiwat,&nbsp;Mongkhon Sompornrattanaphan,&nbsp;Torpong Thongngarm,&nbsp;Chamard Wongsa","doi":"10.12932/AP-060323-1559","DOIUrl":"https://doi.org/10.12932/AP-060323-1559","url":null,"abstract":"<p><strong>Background: </strong>Food allergy affects the patient's quality of life (QoL) and leads to anxiety and depression. In addition to routine treatment, QoL evaluation should also be performed in patients with food allergies. The validated Food Allergy Quality of Life Questionnaire - Adult Form (FAQLQ-AF) and Food Allergy Independent Measure - Adult Form (FAIM-AF) have been well accepted and available in many languages.</p><p><strong>Objective: </strong>Translate FAQLQ-AF and FAIM-AF into Thai and perform reliability and validity tests in Thai adult patients with food allergies.</p><p><strong>Methods: </strong>The translation process was performed according to the ISPOR Task Force for Translation and Cultural Adaptation. Participants 18 years or older and with physician-diagnosed food allergies were included in the study. Thai versions of FAQLQ-AF and FAIM-AF were administered to participants at baseline and after two weeks. The intraclass correlation coefficient and Cronbach's α coefficient were evaluated to demonstrate both questionnaires' test-retest reliability and internal consistency.</p><p><strong>Results: </strong>The study included 104 participants. The Thai version of FAQLQ-AF and FAIM-AF demonstrated good reliability, with intraclass correlation coefficients of 0.83 (95%CI 0.76, 0.88) and 0.85 (95%CI 0.79, 0.90), respectively. The validity was excellent, with Cronbach's α coefficient of 0.91 and 0.92, respectively. Both questionnaires were moderately correlated (r = 0.69, P < 0.001), but poorly correlated with the 36-Item Short Form Survey, which is usually used to evaluate general health status.</p><p><strong>Conclusions: </strong>To evaluate the QoL in adult patients with food allergies, the Thai versions of FAQLQ-AF and FAIM-AF are valid, reliable, and more suitable than the general questionnaire.</p>","PeriodicalId":8552,"journal":{"name":"Asian Pacific journal of allergy and immunology","volume":" ","pages":""},"PeriodicalIF":5.0,"publicationDate":"2023-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49688588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefits of mobile messenger application in caregivers of food allergy children. 移动信使应用程序在食物过敏儿童护理人员中的好处。
IF 5 4区 医学 Q3 ALLERGY Pub Date : 2023-10-23 DOI: 10.12932/AP-210423-1592
Kranjana Chayutimaphan, Jetsada Arnin, Adithep Sawatchai, Watcharoot Kanchongkittiphon, Wiparat Manuyakorn

Background: Unintentional exposure is common in children with food allergies.

Objective: To assess the benefits of newly developed food allergy application.

Methods: Caregivers of children with confirmed immediate reactions to food were enrolled to use the "Kinchew" application for one month. Kinchew provides the detail of food allergens after typing the name of specific food in the chat box. Then, the app provides the product image and detail of food allergens. Kinchew also has a menu for recording food diaries and videos on managing food allergies. Kinchew users were asked to assess their confidence in dealing with food allergies assessed by the questionnaire using 5 points Likert scale. The number of patients who experienced allergic reactions from unintentional food exposure was recorded after using Kinchew.

Results: Seventy caregivers were enrolled. Wheat was the most common causative food in 67% of the participants. All participants used Kinchew with a total use of 1,754 times, classified as food items searching 1080 times (62%), and recorded their food diary 674 times (38%). The number of patients who experienced allergic reactions from unintentional exposure significantly decreased from 61 (87%) to 31 (44%), p < 0.001.The user's confidence in choosing food improved significantly compared to the baseline score. In the subgroup analysis of the type of causative food, a significant improvement in confidence in food choosing was demonstrated in wheat and multiple food allergy groups.

Conclusions: Well-designed food allergy mobile applications could improve caregivers' confidence in dealing with food allergies and reduce unintentional food exposure.

背景:非故意接触在食物过敏的儿童中很常见。目的:评估新开发的食物过敏应用的益处。方法:已确认对食物有即时反应的儿童的护理人员被招募使用“Kinchew”应用程序一个月。Kinchew在聊天框中键入特定食物的名称后,提供食物过敏原的详细信息。然后,该应用程序提供产品图像和食物过敏原的详细信息。Kinchew还有一个菜单,用于记录食物日记和管理食物过敏的视频。Kinchew使用者被要求使用5分Likert量表评估他们对处理食物过敏的信心。在使用Kinchew后,记录了因无意食物暴露而出现过敏反应的患者人数。结果:70名护理人员被纳入。在67%的参与者中,小麦是最常见的致病食物。所有参与者使用Kinchew的总次数为1754次,分类为食品搜索1080次(62%),并记录他们的食品日记674次(38%)。因非故意接触而出现过敏反应的患者人数从61人(87%)显著减少到31人(44%),p<0.001。与基线评分相比,使用者选择食物的信心显著提高。在致病食物类型的亚组分析中,小麦和多种食物过敏组的食物选择信心显著提高。结论:精心设计的食物过敏移动应用程序可以提高护理人员处理食物过敏的信心,并减少无意的食物接触。
{"title":"Benefits of mobile messenger application in caregivers of food allergy children.","authors":"Kranjana Chayutimaphan,&nbsp;Jetsada Arnin,&nbsp;Adithep Sawatchai,&nbsp;Watcharoot Kanchongkittiphon,&nbsp;Wiparat Manuyakorn","doi":"10.12932/AP-210423-1592","DOIUrl":"https://doi.org/10.12932/AP-210423-1592","url":null,"abstract":"<p><strong>Background: </strong>Unintentional exposure is common in children with food allergies.</p><p><strong>Objective: </strong>To assess the benefits of newly developed food allergy application.</p><p><strong>Methods: </strong>Caregivers of children with confirmed immediate reactions to food were enrolled to use the \"Kinchew\" application for one month. Kinchew provides the detail of food allergens after typing the name of specific food in the chat box. Then, the app provides the product image and detail of food allergens. Kinchew also has a menu for recording food diaries and videos on managing food allergies. Kinchew users were asked to assess their confidence in dealing with food allergies assessed by the questionnaire using 5 points Likert scale. The number of patients who experienced allergic reactions from unintentional food exposure was recorded after using Kinchew.</p><p><strong>Results: </strong>Seventy caregivers were enrolled. Wheat was the most common causative food in 67% of the participants. All participants used Kinchew with a total use of 1,754 times, classified as food items searching 1080 times (62%), and recorded their food diary 674 times (38%). The number of patients who experienced allergic reactions from unintentional exposure significantly decreased from 61 (87%) to 31 (44%), p < 0.001.The user's confidence in choosing food improved significantly compared to the baseline score. In the subgroup analysis of the type of causative food, a significant improvement in confidence in food choosing was demonstrated in wheat and multiple food allergy groups.</p><p><strong>Conclusions: </strong>Well-designed food allergy mobile applications could improve caregivers' confidence in dealing with food allergies and reduce unintentional food exposure.</p>","PeriodicalId":8552,"journal":{"name":"Asian Pacific journal of allergy and immunology","volume":" ","pages":""},"PeriodicalIF":5.0,"publicationDate":"2023-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49688584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Articular involvement in Henoch-Schönlein Purpura: A review of literature. Henoch Schönlein Purpura的关节受累:文献综述。
IF 5 4区 医学 Q3 ALLERGY Pub Date : 2023-10-23 DOI: 10.12932/AP-220523-1622
Victor Gonzalez-Uribe, Ricardo Martínez-Tenopala, Ana Paula Solórzano-Anduiza, María Fernández-De La Torre, Zaira S Mojica-Gonzalez

Background: Henoch-Schönlein purpura (HSP), the most typical kind of pediatric vasculitis, can also affect adults. Over the last 10 years, research has been increasing on improvements in HSP diagnosis, physiopathology, symptoms, and therapy. Joint involvement is highly frequent in this condition; however, it typically undergoes spontaneous resolution and does not lead to long-term complications.

Objective: To provide a deeper understanding of the constituting pathogenic mechanisms and clinical presentation of articular involvement, focusing on the effect of neutrophil activation on systemic small vessels.

Methods: This literature review utilized a systematic search of academic databases, employing specific keywords to select recent peer-reviewed articles and scholarly sources on the topic.

Results: The manifestations of joint involvement in HSP can vary in severity and frequency. Non-steroidal anti-inflammatory medications or acetaminophen are considered the first-line treatment for joint pain; however, corticosteroids may help achieve quick remission. In cases where standard treatment fails or manifestations persist, immunosuppressive drugs like rituximab, methotrexate, cyclophosphamide, or azathioprine have been used.

Conclusions: While it tends to resolve without lasting joint damage, accurate diagnosis and appropriate management are crucial to ensure optimal patient outcomes.

背景:过敏性紫癜(HSP)是最典型的儿童血管炎,也会影响成人。在过去的10年里,对HSP诊断、病理生理学、症状和治疗的改进研究不断增加。在这种情况下,联合参与的频率很高;然而,它通常会自发消退,不会导致长期并发症。目的:深入了解中性粒细胞活化对全身小血管的影响,了解关节受累的构成、发病机制和临床表现。方法:这篇文献综述利用了对学术数据库的系统搜索,使用特定的关键词来选择最近关于该主题的同行评审文章和学术来源。结果:HSP关节受累的表现在严重程度和频率上各不相同。非甾体抗炎药或对乙酰氨基酚被认为是治疗关节疼痛的一线药物;然而,皮质类固醇可能有助于快速缓解。在标准治疗失败或症状持续的情况下,已使用免疫抑制药物,如利妥昔单抗、甲氨蝶呤、环磷酰胺或硫唑嘌呤。结论:虽然它倾向于在没有持久关节损伤的情况下解决,但准确的诊断和适当的管理对于确保患者的最佳结果至关重要。
{"title":"Articular involvement in Henoch-Schönlein Purpura: A review of literature.","authors":"Victor Gonzalez-Uribe,&nbsp;Ricardo Martínez-Tenopala,&nbsp;Ana Paula Solórzano-Anduiza,&nbsp;María Fernández-De La Torre,&nbsp;Zaira S Mojica-Gonzalez","doi":"10.12932/AP-220523-1622","DOIUrl":"https://doi.org/10.12932/AP-220523-1622","url":null,"abstract":"<p><strong>Background: </strong>Henoch-Schönlein purpura (HSP), the most typical kind of pediatric vasculitis, can also affect adults. Over the last 10 years, research has been increasing on improvements in HSP diagnosis, physiopathology, symptoms, and therapy. Joint involvement is highly frequent in this condition; however, it typically undergoes spontaneous resolution and does not lead to long-term complications.</p><p><strong>Objective: </strong>To provide a deeper understanding of the constituting pathogenic mechanisms and clinical presentation of articular involvement, focusing on the effect of neutrophil activation on systemic small vessels.</p><p><strong>Methods: </strong>This literature review utilized a systematic search of academic databases, employing specific keywords to select recent peer-reviewed articles and scholarly sources on the topic.</p><p><strong>Results: </strong>The manifestations of joint involvement in HSP can vary in severity and frequency. Non-steroidal anti-inflammatory medications or acetaminophen are considered the first-line treatment for joint pain; however, corticosteroids may help achieve quick remission. In cases where standard treatment fails or manifestations persist, immunosuppressive drugs like rituximab, methotrexate, cyclophosphamide, or azathioprine have been used.</p><p><strong>Conclusions: </strong>While it tends to resolve without lasting joint damage, accurate diagnosis and appropriate management are crucial to ensure optimal patient outcomes.</p>","PeriodicalId":8552,"journal":{"name":"Asian Pacific journal of allergy and immunology","volume":" ","pages":""},"PeriodicalIF":5.0,"publicationDate":"2023-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49688583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Asian Pacific journal of allergy and immunology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1